CA2154413A1 - Compositions pharmaceutiques a base de fluoxetine - Google Patents

Compositions pharmaceutiques a base de fluoxetine

Info

Publication number
CA2154413A1
CA2154413A1 CA002154413A CA2154413A CA2154413A1 CA 2154413 A1 CA2154413 A1 CA 2154413A1 CA 002154413 A CA002154413 A CA 002154413A CA 2154413 A CA2154413 A CA 2154413A CA 2154413 A1 CA2154413 A1 CA 2154413A1
Authority
CA
Canada
Prior art keywords
formulation
weight
relation
set forth
total weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002154413A
Other languages
English (en)
Inventor
Flavia Arce Mendizabal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lilly SA
Original Assignee
Lilly SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly SA filed Critical Lilly SA
Priority to CA002154413A priority Critical patent/CA2154413A1/fr
Publication of CA2154413A1 publication Critical patent/CA2154413A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002154413A 1995-07-21 1995-07-21 Compositions pharmaceutiques a base de fluoxetine Abandoned CA2154413A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002154413A CA2154413A1 (fr) 1995-07-21 1995-07-21 Compositions pharmaceutiques a base de fluoxetine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002154413A CA2154413A1 (fr) 1995-07-21 1995-07-21 Compositions pharmaceutiques a base de fluoxetine

Publications (1)

Publication Number Publication Date
CA2154413A1 true CA2154413A1 (fr) 1997-01-22

Family

ID=4156272

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002154413A Abandoned CA2154413A1 (fr) 1995-07-21 1995-07-21 Compositions pharmaceutiques a base de fluoxetine

Country Status (1)

Country Link
CA (1) CA2154413A1 (fr)

Similar Documents

Publication Publication Date Title
EP0693281B1 (fr) Formulations pharmaceutiques contenant de la fluoxétine
CZ286723B6 (cs) Tablety dispergovatelné ve vodě
JP3996626B2 (ja) 口腔内速崩壊錠
RU2174837C2 (ru) Быстрораспадающаяся готовая препаративная форма трамадола или соли трамадола
EP0716852B1 (fr) Formulations pharmaceutiques contenant du cefaclore
WO2006115770A2 (fr) Preparations pharmaceutiques d'olazanpine en comprimes a desintegration orale
AU2004262964A1 (en) Solid dispersible and/or orodispersible non-filmy containing at least one type of active substance pharmaceutical composition and method for the preparation thereof
JP5561885B2 (ja) ミルタザピンの新しい配合物
EP0319074A1 (fr) Composition pharmaceutique et procédé de sa préparation
CA2154413A1 (fr) Compositions pharmaceutiques a base de fluoxetine
CZ286719B6 (cs) Tablety s obsahem lamotriginu dispergovatelné ve vodě
MXPA00002290A (en) Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20060721